Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Journal of Neurology|December 21, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and visionMihaela Nicolescu, Vivien Häußler, Friedemann Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disordersFrederike Cosima Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Annals of Neurology|December 12, 2023
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGADAnkelien Duchow, Judith Bellmann-Strobl, Tim Friede, et al.
Journal of Neuroinflammation|January 21, 2012
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsSven Jarius, Klemens Ruprecht, Brigitte Wildemann, et al.
The Lancet Regional Health. Europe|January 5, 2026
Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyJuliette Brenner, Anna E M Bastiaansen, Mar Guasp, et al.
Radiology|November 12, 2024
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study CohortClaudia Chien, Vera Cruz E Silva, Emanuel Geiter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2021
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum DisordersMarius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, et al.
Brain : a Journal of Neurology|March 8, 2022
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 diseaseThomas Grüter, Franziska E Möllers, Anja Tietz, et al.
Annals of Neurology|June 15, 2022
Longitudinal Retinal Changes in MOGADFrederike Cosima Oertel, Elias S Sotirchos, Hanna G Zimmermann, et al.
Frontiers in Immunology|April 28, 2025
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)Julian Reza Kretschmer, Daria Tkachenko, Tania Kümpfel, et al.
Pageof 12